Patients with pulmonary hypertension associated with congenital heart disease make up an increasing proportion of the total pulmonary hypertension population who bring with them added complexity ...

Penumbra has completed subject enrolment in the multi-centre, randomised controlled trial, STORM-PE, which assesses the computer-assisted vacuum thrombectomy (CAVT) using the company’s Lightning Flash ...

Key points A 57-year-old man presented to the emergency department with back and right upper quadrant abdominal pain that progressed to painful right leg swelling over a few days. His vital signs at ...

CONSIDERABLE progress has been made in recent years in the understanding of thromboembolic disease and also in the ability to diagnose acute pulmonary embolism. Radiologists have learned to ...

Background In patients with acute pulmonary embolism (PE), rapid and accurate risk assessment is paramount in selecting the appropriate treatment strategy. The prognostic value of right ventricular ...

Spain cDivision of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, USA dCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA eSection ...

Keros Therapeutics will no longer develop the fusion protein cibotercept for pulmonary arterial hypertension, a move that the biotech on Thursday said triggered a 45% reduction in force. The layoffs ...

Of note, further reduction of pulmonary fibrosis occurred in the second year of treatment; the slow improvement of fibrosis after serological remission represents a new aspect in SSc-ILD. The ...

Aim: To quantify the incidence of unsuspected pulmonary emboli (PE) in an unselected inpatient ... Where PE was found, the level of the most proximal thrombus was identified. Patient age, length of ...

The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary ...